DELRAY BEACH, Fla., Oct. 31, 2025 /PRNewswire/ — According to MarketsandMarkets™, The agriculture biotechnology market is ...
Intellia Therapeutics, Inc. is rated Hold due to uncertainty from dosing pause in its MAGNITUDE program for ATTR. Learn more ...
In a separate 2024 study, researchers also made mice temporarily transparent. The study, published in Science, showed that ...
The mice model technologies market offers significant opportunities driven by advancements in genetic engineering, particularly CRISPR/Cas9, fueling drug discovery in oncology, neurobiology, and ...
Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
Advances in cancer immunotherapy from immune checkpoint modulation to adoptive cell transfer of tumour-infiltrating ...
Traditional breeding and genetic modification methods have struggled to keep pace with the rapid evolution of plant viruses. CRISPR/Cas systems, originally derived from bacterial immune responses, ...
The scientist responsible for creating the world’s first “genetically modified” babies has just been sentenced to three years ...
We have the tech to make designer babies but we are not ready for it yet. Read more at straitstimes.com. Read more at straitstimes.com.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback